ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
40 announcements with these filters
Consolidated sales rose 74.6% to ₹1,122.7 Cr, aided by the Comfort Click acquisition. Domestic grew 29.2% in Q2 but only 13.3% in H1. Management gave no Comfort Click margin figures when pressed.
Zydus Wellness reported Q2 FY27 consolidated net sales of ₹11,227 million, up 74.6% YoY. EBITDA grew 271.7% to ₹855 million on strong brand momentum.
Q2 FY27 deck discloses no group P&L numbers. Brands report double-digit growth (Nutralite, Sugar Free, Complan, Everyuth), Max Protein EBITDA expanded, and no guidance is given.
Zydus Wellness Ltd reported revenue from operations of ₹1,127 Cr (+73.2% YoY) and net profit of ₹5.1 Cr for Q2 FY27.
Zydus Wellness clarified that it received a notice from FSSAI regarding alleged misleading product claims. The company stated that its labels are factual and supported by scientific substantiation.
Zydus Wellness Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Zydus Wellness Limited announced the resignation of Mr. Arijit Sengupta, Chief Marketing Officer, effective September 18, 2026.
Zydus Wellness clarified to NSE that the spurt in volume is purely market-driven with no undisclosed information. The company confirmed all Reg 30 disclosures have been made.
Zydus Wellness Ltd has received an ESG score of 71.7 from SES ESG Research Pvt. Ltd., improving from the previous score of 70.
Zydus Wellness Limited has filed the transcript of its 32nd Annual General Meeting held on August 4, 2026. This document records the proceedings of the meeting.
Zydus Wellness Limited appointed Mr. Kapil Sharma as Chief Revenue Officer (India and Indian subcontinent) effective September 1, 2026. He joins as part of Senior Management.
Zydus Wellness reported the transmission of 27,250 equity shares to promoter Prashant Babubhai Patel from the late Jasodaben Babubhai Patel. This is a non-market transfer.
CARE Ratings assigned a 'CARE AA+; Stable' rating to the Rs. 12 Crore long-term bank facilities of Zydus Wellness Products Limited, a material subsidiary.
Zydus Wellness received an upgraded 'Strong' ESG rating from CRISIL, with a Crisil ESG score of 66 and a Crisil Core ESG score of 70.
Zydus reported 66.7% revenue growth, heavily distorted by the Complan (ComfortClick) acquisition. Organic performance was mixed as seasonal brands faced weather headwinds while personal care and international segments showed strong double-digit momentum.
Zydus Wellness Ltd appointed Mr. Apurva S. Diwanji as an Independent Director for a five-year term, approved by shareholders at the company's 32nd Annual General Meeting.
Zydus Wellness Ltd announced the voting results of its 32nd Annual General Meeting. All resolutions, including the dividend declaration, were passed with the requisite majority.
Zydus Wellness reported a 66.7% increase in net sales to ₹142.99 Crore for Q1 FY27. EBITDA grew 55.3% to ₹24.17 Crore.
Zydus Wellness Q1 FY27 earnings presentation highlights strong double-digit growth in core portfolios like Sugar Free and Everyuth, despite weather-related headwinds impacting seasonal brands like Glucon-D and Nycil.
Zydus Wellness Ltd reported revenue from operations of ₹1,437 Cr (+66.9% YoY) and net profit of ₹118.9 Cr (-7.0% YoY) for Q1 FY27.
Zydus Wellness will hold a Board Meeting on August 4, 2026. The board will consider unaudited financial results for the quarter ended June 30, 2026.
Zydus Wellness subsidiary, Comfort Click Limited, received a ₹0.135 Crore penalty from Polish tax authorities. The fine relates to delayed filing of Intrastat declarations.
Zydus Wellness convened its Annual General Meeting for August 4, 2026. Key agenda items include adopting financial statements and declaring a ₹1.20 per share final dividend.
Zydus Wellness submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's environmental, social, and governance disclosures and performance.
Zydus Wellness submitted its Integrated Annual Report for FY 2025-26. The 32nd Annual General Meeting is scheduled for August 4, 2026.
Zydus Wellness appointed Dr. Shyam Ramakrishnan as Chief Scientific Officer. The appointment is effective from July 1, 2026.
Zydus Wellness incorporated a step-down subsidiary in Dubai with AED 300,000 capital. This move supports business expansion in the food and nutrition sector.
Zydus Wellness acquired 100% stake in Ireland-based Zydus Wellness (EU) Limited. The acquisition supports business expansion in the Vitamins, Minerals, and Supplements sector.
Samar Babubhai Patel bought 500 shares at ₹2 each, totalling ₹1,000 (₹0.00 Crore). The acquisition was via open‑market trade on NSE and disclosed under PIT regulations.
Rupa Nitinkumar Parekh, spouse of a Designated Person, acquired 4,000 shares of Zydus Wellness for ₹0.20 Crore. The open market transaction increases the relative's stake to 0.00%.